Top

Published in:

01-04-2013

Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China

Authors: Lin Yuan, Luxin Qiao, Feili Wei, Jiming Yin, Lifeng Liu, Yunxia Ji, Davey Smith, Ning Li, Dexi Chen

Published in: Journal of NeuroVirology | Issue 2/2013

Abstract

In the current era of highly active antiretroviral therapy (HAART), the incidence of HIV dementia has declined, but the prevalence of HIV-associated neurocognitive disorder (HAND) remains high. HIV-induced systemic and localized inflammation is considered to be one of the mechanisms of HAND. Changes in cytokine levels in the cerebrospinal fluid (CSF) during HIV infection might help to identify HAND. To investigate whether the cytokine profile of the CSF during HIV infection could be used as a biomarker of HAND, we compared cytokine levels in the CSF of HIV-infected cases with and without neurocognitive impairment. Cytokine concentrations in the CSF were measured by quantification bioassays (Luminex xMAP). HIV-infected cases with neurocognitive impairment demonstrated higher levels of interleukin (IL)-8, monocyte chemotactic protein (MCP)-1, induced protein (IP)-10, and granulocyte colony-stimulating factor (G-CSF) in the CSF than those without neurocognitive impairment (G-CSF (p = 0.0003), IL-8 (p = 0.0046), IP-10 (p < 0.0001), and MCP-1 (p < 0.0001)). There was no significant impact of HAART on cytokine levels in the CSF, except for IP-10, which was higher in HAART-treated patients with impaired cognition (p = 0.0182). Findings from this preliminary study suggest that elevated levels of the cytokines IL-8, MCP-1, G-CSF, and IP-10 in the CSF are associated with neurocognitive impairment in HIV infection, and these cytokines likely represent a biomarker profile for HAND.

Al-Khindi T, Zakzanis KK, van Gorp WG (2011) Does antiretroviral therapy improve HIV-associated cognitive impairment? A quantitative review of the literature. J Int Neuropsychol Soc 17:956–69. doi:10.1017/S1355617711000968 PubMedCrossRef

Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M et al (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789–99PubMedCrossRef

Aquaro S, Ronga L, Pollicita M, Antinori A, Ranazzi A, Perno CF (2005) Human immunedeficiency virus infection and acquired immunodeficiency syndrome dementia complex: role of cells of monocyte-macrophage lineage. J Neurovirol 11:58–66. doi:10.1080/13550280500513416 PubMedCrossRef

Bandaru VV, McArthur JC, Sacktor N, Cutler RG, Knapp EL, Mattson MP et al (2007) Associative and predictive biomarkers of dementia in HIV-1-infected patients. Neurology 68:1481–7PubMedCrossRef

Bebell LM, Passmore JA, Williamson C, Mlisana K, Iriogbe I, Loggerenberg F et al (2008) Relationship between levels of inflammatory cytokines in the genital tract and CD4+ cell counts in women with acute HIV-1 infection. J Infect Dis 198:710–4. doi:10.1086/590503 PubMedCrossRef

Clifford DB, Fagan AM, Holtzman DM, Morris JC, Teshome M, Shah AR et al (2009) CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology 73:1982–7PubMedCrossRef

Epstein LG, Gendelman HE (1993) Human immunodeficiency virus type-1 infection of the nervous system: pathogenetic mechanisms. Ann Neurol 33:429–36PubMedCrossRef

Eugenin EA, Osiecki K, Lopez L, Goldstein H, Calderon TM, Berman JW (2006) CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood–brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J Neurosci 26:1098–106. doi:10.1523/JNEUROSCI.3863-05.2006 PubMedCrossRef

Gonzalez E, Rovin BH, Sen L, Cooke G, Dhanda R, Mummidi S (2002) HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci U S A 99:13795–800PubMedCrossRef

Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F et al (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75:2087–96PubMedCrossRef

Hopkins SJ (1995) Cytokines and the nervous system. I: Expression and recognition. Trends Neurosci 18:83–8PubMedCrossRef

Lane BR, King SR, Bock PJ, Strieter RM, Coffey MJ, Markovitz DM (2003) The C-X-C chemokine IP-10 stimulates HIV-1 replication. Virology 307:122–34. doi:10.1016/S0042-6822(02)00045-4 PubMedCrossRef

Lehmann MH, Masanetz S, Kramer S, Erfle V (2006) HIV-1 Nef upregulates CCL2/MCP-1 expression in astrocytes in a myristoylation- and calmodulin-dependent manner. J Cell Sci 119:4520–30. doi:10.1242/jcs.03231 PubMedCrossRef

Letendre SL, Zheng JC, Kaul M, Yiannoutsos CT, Ellis RJ, Taylor MJ et al (2011) Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals. J Neurovirol 17:63–9. doi:10.1007/s13365-010-0013-2 PubMedCrossRef

McGuire D (2009) CSF biomarkers in HIV dementia: through a glass darkly. Neurology 73:1942–4PubMedCrossRef

Nixon DE, Landay AL (2010) Biomarkers of immune dysfunction in HIV. Curr Opin HIV AIDS 5(6):498–503. doi:10.1097/COH.0b013e32833ed6f4 PubMedCrossRef

Persidsky Y, Zheng J, Miller D, Gendelman HE (2000) Mononuclear phagocytes mediate blood–brain barrier compromise and neuronal injury during HIV-1-associated dementia. J Leukoc Biol 68:413–22PubMed

Price RW, Epstein LG, Becker JT, Cinque P, Gisslen M, Pulliam L et al (2007) Biomarkers of HIV-1 CNS infection and injury. Neurology 69:1781–8PubMedCrossRef

Roberts L, Passmore JA, Williamson C, Little F, Bebell LM, Mlisana K et al (2010) Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression. AIDS 24:819–31. doi:10.1097/QAD.0b013e3283367836 PubMedCrossRef

Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J et al (2007) The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 21:1915–21. doi:10.1097/QAD.0b013e32828e4e27 PubMedCrossRef

Rubin L, Staddon J (1999) The cell biology of the blood–brain barrier. Ann Rev NeuroSci 22:11–27. doi:10.1146/annurev.neuro.22.1.11 PubMedCrossRef

Shah A, Kumar A (2010) HIV-1 gp120-mediated increases in IL-8 production in astrocytes are mediated through the NF-κB pathway and can be silenced by gp120-specific siRNA. J Neuroinflammation 7:96–101PubMedCrossRef

Sui Y, Potula R, Pinson D, Adany I, Li Z, Day J et al (2003) Microarray analysis of cytokine and chemokine genes in the brains of macaques with SHIV-encephalitis. J Med Primatol 32:229–39. doi:10.1034/j.1600-0684.2003.00030.x PubMedCrossRef

Williams K, Hickey WF (2002) Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neurosci 25:537–62. doi:10.1146/annurev.neuro.25.112701.142822 PubMedCrossRef

Yang B, Akhter S, Chaudhuri A, Kanmogne GD (2009) HIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood–brain barrier: modulatory effects of STAT1 signaling. Microvasc Res 77:212–9. doi:10.1016/j.mvr.2008.11.003 PubMedCrossRef

Title: Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China
Authors: Lin Yuan
Luxin Qiao
Feili Wei
Jiming Yin
Lifeng Liu
Yunxia Ji
Davey Smith
Ning Li
Dexi Chen
Publication date: 01-04-2013
Publisher: Springer US
Published in: Journal of NeuroVirology / Issue 2/2013
Print ISSN: 1355-0284
Electronic ISSN: 1538-2443
DOI: https://doi.org/10.1007/s13365-013-0150-5

2024 ASCO Annual Meeting

Springer Medicine

Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China

Abstract

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2013

National Institute on Drug Abuse symposium report: drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia

Reversible severe encephalitis and word deafness following rapid immune reconstitution in AIDS: a case report

Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders

Hepatitis E with Gullain–Barré syndrome: still a rare association

In fond remembrance and tribute to Dr. Kuan-Teh Jeang, M.D., Ph.D

VZV uveoretino meningitis following dental treatment